CRS-207: Phase IIb data

Top-line data from the open-label, North American Phase IIb ECLIPSE trial in 303 patients with metastatic pancreatic cancer who failed

Read the full 207 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE